Powered by the Evidence-based Practice Centers
Evidence Reports All of EHC
Evidence Reports All of EHC

SHARE:

FacebookTwitterFacebookPrintShare

Prostate Cancer Screening Harms

NOMINATED TOPIC | October 3, 2023

1. What is the decision or change (e.g., clinical topic, practice guideline, system design, delivery of care) you are facing or struggling with where a summary of the evidence would be helpful?

A 12 or 18 core prostate blind biopsy. One million dangerous prostate blind (TRUS) biopsies are performed in the USA each year and they should be banned: Invasive, dangerous, degrading and unnecessary. Men with a high PSA tests result are often sent to an urologist for a blind biopsy. You may not own your biopsy samples. Blind prostate biopsy cost in the USA is at least $3 billion annually. False positives and false negatives do occur. Men should be told about other options; Percent free PSA test, 4Kscore test, SelectMDX, PCA3 test or a 3T MRI test before receiving a blind biopsy. These tests can often eliminate the need for a risky and invasive blind biopsy. Unfortunately, sometimes insurance companies may not pay for other tests. Insertion of 12 or 18 large hollow needles through the dirty rectum into a gland the size of a walnut, a blind biopsy can result in pain, infections, a risk of temporary or permanent erectile dysfunction https://www.youtube.com/watch?v=IRbJPOgIU0k. Biopsies can cause, urinary problems, An infection rate of 7.2%, up to a 6.9% hospitalization rate within 30 days from a complication, sometimes even death from sepsis (About 1.3 to 3.5 deaths per 1,000). There is also debate that a biopsy may spread cancer because of needle tracking. A blind biopsy is degrading and can also increase PSA reading for several weeks or months, further frightening men into unnecessary treatment. Blind biopsies are almost never performed on other organs.

Page last reviewed December 2023
Page originally created October 2023

Internet Citation: Prostate Cancer Screening Harms. Content last reviewed December 2023. Effective Health Care Program, Agency for Healthcare Research and Quality, Rockville, MD.
https://effectivehealthcare.ahrq.gov/get-involved/nominated-topics/prostate-cancer

Select to copy citation